ES2144548T3 - Derivado de naftiridinio, procedimiento para su preparacion, anticuerpos contra este derivado y la aplicacion del indicado anticuerpo. - Google Patents

Derivado de naftiridinio, procedimiento para su preparacion, anticuerpos contra este derivado y la aplicacion del indicado anticuerpo.

Info

Publication number
ES2144548T3
ES2144548T3 ES95112150T ES95112150T ES2144548T3 ES 2144548 T3 ES2144548 T3 ES 2144548T3 ES 95112150 T ES95112150 T ES 95112150T ES 95112150 T ES95112150 T ES 95112150T ES 2144548 T3 ES2144548 T3 ES 2144548T3
Authority
ES
Spain
Prior art keywords
derivative
naftiridinio
procedure
preparation
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95112150T
Other languages
English (en)
Inventor
Seikoh Horiuchi
Kazuharu Ienaga
Ko Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2144548T3 publication Critical patent/ES2144548T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN NUEVO DERIVADO DE NAFTIRIDINIO; A UN METODO PARA LA PRODUCCION DE DICHO DERIVADO; A UN ANTICUERPO PREPARADO UTILIZANDO DICHO DERIVADO COMO HAPTENO; A UN METODO PARA EL DIAGNOSTICO DE LA DIABETES, DE COMPLICACIONES DIABETICAS Y DE COMPLICACIONES RELACIONADAS CON LA DIABETES, EL ENVEJECIMIENTO, LAS ENFERMEDADES RELACIONADAS CON EL ENVEJECIMIENTO, ETC. UTILIZANDO DICHO DERIVADO O ANTICUERPO DEL MISMO; Y A UN METODO PARA EVALUAR EL EFECTO DE PRODUCTOS FARMACEUTICOS EFECTIVOS PARA TALES ENFERMEDADES RELACIONADAS CON LA DIABETES, EL ENVEJECIMIENTO Y ENFERMEDADES RELACIONADAS.
ES95112150T 1994-08-05 1995-08-02 Derivado de naftiridinio, procedimiento para su preparacion, anticuerpos contra este derivado y la aplicacion del indicado anticuerpo. Expired - Lifetime ES2144548T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20451794A JP3242792B2 (ja) 1994-08-05 1994-08-05 ナフチリジニウム誘導体

Publications (1)

Publication Number Publication Date
ES2144548T3 true ES2144548T3 (es) 2000-06-16

Family

ID=16491851

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95112150T Expired - Lifetime ES2144548T3 (es) 1994-08-05 1995-08-02 Derivado de naftiridinio, procedimiento para su preparacion, anticuerpos contra este derivado y la aplicacion del indicado anticuerpo.

Country Status (7)

Country Link
US (1) US5686251A (es)
EP (1) EP0695750B1 (es)
JP (1) JP3242792B2 (es)
AT (1) ATE190060T1 (es)
DE (1) DE69515228T2 (es)
DK (1) DK0695750T3 (es)
ES (1) ES2144548T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613537B2 (en) 2000-02-29 2003-09-02 Nippon Zoki Pharmaceutical Co., Ltd. Pyrrolopyridinium derivatives
TWI243055B (en) 2000-04-13 2005-11-11 Nippon Zoki Pharmaceutical Co Pharmaceutical composition for use in treatment of dermatitis
JP2005504807A (ja) * 2001-09-26 2005-02-17 バイエル・フアーマシユーチカルズ・コーポレーシヨン 抗糖尿病薬としての１，８−ナフチリジン誘導体
ES2274268T3 (es) * 2002-05-31 2007-05-16 Bayer Pharmaceuticals Corporation Compuestos y composiciones para el tratamiento de la diabetes y trastornos relacionados con la diabetes.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837169A (en) * 1981-07-01 1989-06-06 Eastman Kodak Company Polypyridine Fluorescent labels for immunoassay
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
IL91648A (en) * 1988-09-22 1997-03-18 Abbott Lab Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
JP3124028B2 (ja) * 1989-08-23 2001-01-15 ノースウェスターン ユニヴァーシティ 還元的にグリコシル化されたｎ―末端アミノ酸に向けられた抗原を使用するグリコシル化されたタンパクの免疫学的測定法
JP3113440B2 (ja) * 1992-03-25 2000-11-27 日本臓器製薬株式会社 ピリジニウム誘導体

Also Published As

Publication number Publication date
ATE190060T1 (de) 2000-03-15
US5686251A (en) 1997-11-11
EP0695750A1 (en) 1996-02-07
JPH0848686A (ja) 1996-02-20
JP3242792B2 (ja) 2001-12-25
DK0695750T3 (da) 2000-08-14
DE69515228D1 (de) 2000-04-06
DE69515228T2 (de) 2000-09-07
EP0695750B1 (en) 2000-03-01

Similar Documents

Publication Publication Date Title
NO20073429L (no) Anvendelse av et antistoff mot interleukin-6-reseptor for fremstilling av et farmasoytisk preparat
CA2424977A1 (en) Process for purifying antibody
FI99086B (fi) Ultraäänivarjoaineita, menetelmä niiden valmistamiseksi ja niiden käyttö diagnostisina aineina
BRPI0515722A (pt) derivados de ácido tretrámico espirocìclicos substituìdos com 2-alcóxi-6-alquil-fenila
SE8803570L (sv) 4h-1-bensopyran-4-on-derivat eller dess salt, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande detsamma som aktiv komponent
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
BR9912702A (pt) Composto e método para a prevenção e/ou para o tratamento de alergias
FI960268A (fi) Menetelmä sairauden diagnosoimiseksi määrittämällä GAGE-tuumorihyljintäantigeenin prekursorien ilmentymistä
EP1600164A3 (de) Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer Pharmazeutischen Zusammensetzung mit dosisabhängiger Wirkung
EP0160260A3 (de) Verfahren zur Immobilisierung von biologischem Material
PT1228024E (pt) Novos compostos de hidronaftaleno, preprados por uma reaccao de abertura de anelcatalisada pelo rodio na presenca de um ligando de fosfina
DK0451082T3 (da) Ophthalmisk produkt
ES2144548T3 (es) Derivado de naftiridinio, procedimiento para su preparacion, anticuerpos contra este derivado y la aplicacion del indicado anticuerpo.
DE3773077D1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE199559T1 (de) N- und o-substituierte aminophenolderivate, zwischenprodukte zu deren herstellung, deren verwendung als hydrolasesubstrate, ein entsprechendes bestimmungsverfahren und hierfür geeignetes diagnostisches mittel
ATE162312T1 (de) Stabiles flüssiges kontroll- bzw. eichserum für die klinische diagnostik
NL183357C (nl) (2.3-dihydro-2.2-dimethyl-benzofuran-7-yloxy-n-methylcarbamoyl)-(n'-alkylcarbamoyl)-sulfiden, werkwijze voor de bereiding daarvan, werkwijze voor de bereiding van een insecticide preparaat alsmede werkwijze voor de bestrijding van insecten.
EP0776650A3 (de) Dentaladhäsive
ATE381536T1 (de) Verfahren zur herstellung von n-methyl-n'- nitroguanidin
DE69019086D1 (de) Verfahren zur Herstellung von künstlichen N-verbundenen Glycoconjugaten.
ATE231492T1 (de) Verfahren zur herstellung von pyrrolamiden
ES2149786T3 (es) Derivados de piridinio.
BR0208295A (pt) Delta1-pirrolinas
ATE120458T1 (de) Dihydropyranderivate, ihre verfahren zur herstellung und ihre verwendung.
BR0207953A (pt) Derivados de caloporosida, processos para a sua preparação e sua aplicação

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 695750

Country of ref document: ES